{"id":1544,"date":"2019-07-16T20:37:59","date_gmt":"2019-07-16T20:37:59","guid":{"rendered":"https:\/\/wp.uthscsa.edu\/nephrology\/?p=1544"},"modified":"2021-03-25T10:11:53","modified_gmt":"2021-03-25T15:11:53","slug":"high-dose-spironolactone-when-patients-with-acute-decompensated-heart-failure-are-resistant-to-loop-diuretics-a-pilot-study","status":"publish","type":"post","link":"https:\/\/lsom.uthscsa.edu\/nephrology\/2019\/07\/16\/high-dose-spironolactone-when-patients-with-acute-decompensated-heart-failure-are-resistant-to-loop-diuretics-a-pilot-study\/","title":{"rendered":"High-Dose Spironolactone When Patients With Acute Decompensated Heart Failure Are Resistant to Loop Diuretics: A Pilot Study"},"content":{"rendered":"<p>16 JULY 2019<\/p>\n<h2><strong>High-Dose Spironolactone When Patients With Acute Decompensated Heart Failure Are Resistant to Loop Diuretics: A Pilot Study<\/strong><\/h2>\n<h6><em>Shweta Bansal, MD; Kristina Munoz, BS; Sonja Brune, MSN; Steven Bailey, MD; Anand Prasad, MD; Chakradhar Velagapudi, PhD<\/em><\/h6>\n<p><strong>Background:<\/strong>\u00a0Resistance to loop diuretics occurs frequently in patients with acute decompensated heart failure (1), and secondary hyperaldosteronism plays a major role (2). Aldosterone antagonists are a standard of care in heart failure but are commonly used at low, nonnatriuretic doses to avoid hyperkalemia (3,\u00a04).<\/p>\n<p><strong>Objective:\u00a0<\/strong>To examine whether the addition of high-dose spironolactone could be safe and effective in selected patients with acute decompensated heart failure.<\/p>\n<p><strong>Methods:<\/strong>\u00a0We did a prospective, single-center, nonrandomized trial with informed consent, institutional review board approval, and prior registration (ClinicalTrials.gov: NCT02823626). Eligible patients were recently hospitalized for heart failure with reduced or preserved ejection fraction and at least 1 symptom (dyspnea, orthopnea, or peripheral swelling) and 1 sign (rales, edema, or radiographic pulmonary edema) of hypervolemia. We excluded patients with acute coronary syndrome, active infection, end-stage liver disease, an estimated glomerular filtration rate less than 30 mL\/min\/1.73 m2, or a serum potassium level of 5.5 mmol\/L or higher; pregnant patients; and those receiving spironolactone at a dosage higher than 25 mg\/d. We weighed patients in their hospital gowns every day using the same scale, and we asked them to indicate their dyspnea level on a 7-point Likert scale.<\/p>\n<p>We identified consecutive patients who lost less than 0.5 kg weight per day despite receiving intravenous furosemide at a dosage of at least 160 mg\/d (with at least 1 dose &gt;80 mg) and patients who, at 48 hours after admission and regardless of diuretic dose, lost less than 0.5 kg per day or had no change in dyspnea. For these patients, we added spironolactone, 100 mg\/d (and patiromer, 8.4 g\/d, if the serum potassium level was &gt;4.3 mmol\/L without potassium supplements). For patients already receiving spironolactone, 25 mg\/d, we increased the dosage to 100 mg\/d. The next day, we increased the dosage to 200 mg\/d if participants lost less than 0.5 kg per day and had an increase in serum creatinine level of less than 26.52 \u00b5mol\/L (0.30 mg\/dL).<\/p>\n<p><strong>Results:<\/strong>\u00a0Of the 316 patients who were potential study participants, 180 responded to loop diuretics before the study team could determine their eligibility (usually because of emergency overnight admissions), 89 met exclusion criteria, and 47 enrolled in the study. Of these, 20 met criteria for high-dose spironolactone and one subsequently withdrew because of mechanical ventilation. The\u00a0Table\u00a0describes baseline characteristics.<\/p>\n<p><a href=\"https:\/\/annals.org\/aim\/article-abstract\/2738163\/high-dose-spironolactone-when-patients-acute-decompensated-heart-failure-resistant\">Continue reading<\/a><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>16 JULY 2019 High-Dose Spironolactone When Patients With Acute Decompensated Heart Failure Are Resistant to Loop Diuretics: A Pilot Study Shweta Bansal, MD; Kristina Munoz, BS; Sonja Brune, MSN; Steven Bailey, MD; Anand Prasad, MD; Chakradhar Velagapudi, PhD Background:\u00a0Resistance to loop diuretics occurs frequently in patients with acute decompensated heart failure (1), and secondary hyperaldosteronism [&hellip;]<\/p>\n","protected":false},"author":111,"featured_media":1550,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"video","meta":{"footnotes":""},"categories":[3],"tags":[],"class_list":["post-1544","post","type-post","status-publish","format-video","has-post-thumbnail","hentry","category-news","post_format-post-format-video"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>High-Dose Spironolactone When Patients With Acute Decompensated Heart Failure Are Resistant to Loop Diuretics: A Pilot Study - Nephrology<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/lsom.uthscsa.edu\/nephrology\/2019\/07\/16\/high-dose-spironolactone-when-patients-with-acute-decompensated-heart-failure-are-resistant-to-loop-diuretics-a-pilot-study\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"High-Dose Spironolactone When Patients With Acute Decompensated Heart Failure Are Resistant to Loop Diuretics: A Pilot Study - Nephrology\" \/>\n<meta property=\"og:description\" content=\"16 JULY 2019 High-Dose Spironolactone When Patients With Acute Decompensated Heart Failure Are Resistant to Loop Diuretics: A Pilot Study Shweta Bansal, MD; Kristina Munoz, BS; Sonja Brune, MSN; Steven Bailey, MD; Anand Prasad, MD; Chakradhar Velagapudi, PhD Background:\u00a0Resistance to loop diuretics occurs frequently in patients with acute decompensated heart failure (1), and secondary hyperaldosteronism [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/lsom.uthscsa.edu\/nephrology\/2019\/07\/16\/high-dose-spironolactone-when-patients-with-acute-decompensated-heart-failure-are-resistant-to-loop-diuretics-a-pilot-study\/\" \/>\n<meta property=\"og:site_name\" content=\"Nephrology\" \/>\n<meta property=\"article:published_time\" content=\"2019-07-16T20:37:59+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-03-25T15:11:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/lsom.uthscsa.edu\/nephrology\/wp-content\/uploads\/sites\/38\/2019\/07\/Bansal-v1-v1-resized.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"666\" \/>\n\t<meta property=\"og:image:height\" content=\"375\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"baumanm\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"baumanm\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/nephrology\\\/2019\\\/07\\\/16\\\/high-dose-spironolactone-when-patients-with-acute-decompensated-heart-failure-are-resistant-to-loop-diuretics-a-pilot-study\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/nephrology\\\/2019\\\/07\\\/16\\\/high-dose-spironolactone-when-patients-with-acute-decompensated-heart-failure-are-resistant-to-loop-diuretics-a-pilot-study\\\/\"},\"author\":{\"name\":\"baumanm\",\"@id\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/nephrology\\\/#\\\/schema\\\/person\\\/1110032d4e6834fc23a37da5c6fbbc11\"},\"headline\":\"High-Dose Spironolactone When Patients With Acute Decompensated Heart Failure Are Resistant to Loop Diuretics: A Pilot Study\",\"datePublished\":\"2019-07-16T20:37:59+00:00\",\"dateModified\":\"2021-03-25T15:11:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/nephrology\\\/2019\\\/07\\\/16\\\/high-dose-spironolactone-when-patients-with-acute-decompensated-heart-failure-are-resistant-to-loop-diuretics-a-pilot-study\\\/\"},\"wordCount\":426,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/nephrology\\\/2019\\\/07\\\/16\\\/high-dose-spironolactone-when-patients-with-acute-decompensated-heart-failure-are-resistant-to-loop-diuretics-a-pilot-study\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/nephrology\\\/wp-content\\\/uploads\\\/sites\\\/38\\\/2019\\\/07\\\/Bansal-v1-v1-resized.jpg\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/lsom.uthscsa.edu\\\/nephrology\\\/2019\\\/07\\\/16\\\/high-dose-spironolactone-when-patients-with-acute-decompensated-heart-failure-are-resistant-to-loop-diuretics-a-pilot-study\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/nephrology\\\/2019\\\/07\\\/16\\\/high-dose-spironolactone-when-patients-with-acute-decompensated-heart-failure-are-resistant-to-loop-diuretics-a-pilot-study\\\/\",\"url\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/nephrology\\\/2019\\\/07\\\/16\\\/high-dose-spironolactone-when-patients-with-acute-decompensated-heart-failure-are-resistant-to-loop-diuretics-a-pilot-study\\\/\",\"name\":\"High-Dose Spironolactone When Patients With Acute Decompensated Heart Failure Are Resistant to Loop Diuretics: A Pilot Study - Nephrology\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/nephrology\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/nephrology\\\/2019\\\/07\\\/16\\\/high-dose-spironolactone-when-patients-with-acute-decompensated-heart-failure-are-resistant-to-loop-diuretics-a-pilot-study\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/nephrology\\\/2019\\\/07\\\/16\\\/high-dose-spironolactone-when-patients-with-acute-decompensated-heart-failure-are-resistant-to-loop-diuretics-a-pilot-study\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/nephrology\\\/wp-content\\\/uploads\\\/sites\\\/38\\\/2019\\\/07\\\/Bansal-v1-v1-resized.jpg\",\"datePublished\":\"2019-07-16T20:37:59+00:00\",\"dateModified\":\"2021-03-25T15:11:53+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/nephrology\\\/#\\\/schema\\\/person\\\/1110032d4e6834fc23a37da5c6fbbc11\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/nephrology\\\/2019\\\/07\\\/16\\\/high-dose-spironolactone-when-patients-with-acute-decompensated-heart-failure-are-resistant-to-loop-diuretics-a-pilot-study\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/lsom.uthscsa.edu\\\/nephrology\\\/2019\\\/07\\\/16\\\/high-dose-spironolactone-when-patients-with-acute-decompensated-heart-failure-are-resistant-to-loop-diuretics-a-pilot-study\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/nephrology\\\/2019\\\/07\\\/16\\\/high-dose-spironolactone-when-patients-with-acute-decompensated-heart-failure-are-resistant-to-loop-diuretics-a-pilot-study\\\/#primaryimage\",\"url\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/nephrology\\\/wp-content\\\/uploads\\\/sites\\\/38\\\/2019\\\/07\\\/Bansal-v1-v1-resized.jpg\",\"contentUrl\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/nephrology\\\/wp-content\\\/uploads\\\/sites\\\/38\\\/2019\\\/07\\\/Bansal-v1-v1-resized.jpg\",\"width\":666,\"height\":375,\"caption\":\"Shweta Bansal, MD - Director of Clinical Research, Associate Professor, Program Director-Nephrology Fellowship\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/nephrology\\\/2019\\\/07\\\/16\\\/high-dose-spironolactone-when-patients-with-acute-decompensated-heart-failure-are-resistant-to-loop-diuretics-a-pilot-study\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/nephrology\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Uncategorized\",\"item\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/nephrology\\\/category\\\/uncategorized\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"News\",\"item\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/nephrology\\\/category\\\/uncategorized\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"High-Dose Spironolactone When Patients With Acute Decompensated Heart Failure Are Resistant to Loop Diuretics: A Pilot Study\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/nephrology\\\/#website\",\"url\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/nephrology\\\/\",\"name\":\"Nephrology\",\"description\":\"Division of Nephrology\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/nephrology\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/nephrology\\\/#\\\/schema\\\/person\\\/1110032d4e6834fc23a37da5c6fbbc11\",\"name\":\"baumanm\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4dbea44cb0a308caca16d860c82c3fa9a1c9af9b073c9e8daccad7e4ed1babe7?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4dbea44cb0a308caca16d860c82c3fa9a1c9af9b073c9e8daccad7e4ed1babe7?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4dbea44cb0a308caca16d860c82c3fa9a1c9af9b073c9e8daccad7e4ed1babe7?s=96&d=mm&r=g\",\"caption\":\"baumanm\"},\"url\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/nephrology\\\/author\\\/baumanm\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"High-Dose Spironolactone When Patients With Acute Decompensated Heart Failure Are Resistant to Loop Diuretics: A Pilot Study - Nephrology","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/lsom.uthscsa.edu\/nephrology\/2019\/07\/16\/high-dose-spironolactone-when-patients-with-acute-decompensated-heart-failure-are-resistant-to-loop-diuretics-a-pilot-study\/","og_locale":"en_US","og_type":"article","og_title":"High-Dose Spironolactone When Patients With Acute Decompensated Heart Failure Are Resistant to Loop Diuretics: A Pilot Study - Nephrology","og_description":"16 JULY 2019 High-Dose Spironolactone When Patients With Acute Decompensated Heart Failure Are Resistant to Loop Diuretics: A Pilot Study Shweta Bansal, MD; Kristina Munoz, BS; Sonja Brune, MSN; Steven Bailey, MD; Anand Prasad, MD; Chakradhar Velagapudi, PhD Background:\u00a0Resistance to loop diuretics occurs frequently in patients with acute decompensated heart failure (1), and secondary hyperaldosteronism [&hellip;]","og_url":"https:\/\/lsom.uthscsa.edu\/nephrology\/2019\/07\/16\/high-dose-spironolactone-when-patients-with-acute-decompensated-heart-failure-are-resistant-to-loop-diuretics-a-pilot-study\/","og_site_name":"Nephrology","article_published_time":"2019-07-16T20:37:59+00:00","article_modified_time":"2021-03-25T15:11:53+00:00","og_image":[{"width":666,"height":375,"url":"https:\/\/lsom.uthscsa.edu\/nephrology\/wp-content\/uploads\/sites\/38\/2019\/07\/Bansal-v1-v1-resized.jpg","type":"image\/jpeg"}],"author":"baumanm","twitter_card":"summary_large_image","twitter_misc":{"Written by":"baumanm","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/lsom.uthscsa.edu\/nephrology\/2019\/07\/16\/high-dose-spironolactone-when-patients-with-acute-decompensated-heart-failure-are-resistant-to-loop-diuretics-a-pilot-study\/#article","isPartOf":{"@id":"https:\/\/lsom.uthscsa.edu\/nephrology\/2019\/07\/16\/high-dose-spironolactone-when-patients-with-acute-decompensated-heart-failure-are-resistant-to-loop-diuretics-a-pilot-study\/"},"author":{"name":"baumanm","@id":"https:\/\/lsom.uthscsa.edu\/nephrology\/#\/schema\/person\/1110032d4e6834fc23a37da5c6fbbc11"},"headline":"High-Dose Spironolactone When Patients With Acute Decompensated Heart Failure Are Resistant to Loop Diuretics: A Pilot Study","datePublished":"2019-07-16T20:37:59+00:00","dateModified":"2021-03-25T15:11:53+00:00","mainEntityOfPage":{"@id":"https:\/\/lsom.uthscsa.edu\/nephrology\/2019\/07\/16\/high-dose-spironolactone-when-patients-with-acute-decompensated-heart-failure-are-resistant-to-loop-diuretics-a-pilot-study\/"},"wordCount":426,"commentCount":0,"image":{"@id":"https:\/\/lsom.uthscsa.edu\/nephrology\/2019\/07\/16\/high-dose-spironolactone-when-patients-with-acute-decompensated-heart-failure-are-resistant-to-loop-diuretics-a-pilot-study\/#primaryimage"},"thumbnailUrl":"https:\/\/lsom.uthscsa.edu\/nephrology\/wp-content\/uploads\/sites\/38\/2019\/07\/Bansal-v1-v1-resized.jpg","articleSection":["News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/lsom.uthscsa.edu\/nephrology\/2019\/07\/16\/high-dose-spironolactone-when-patients-with-acute-decompensated-heart-failure-are-resistant-to-loop-diuretics-a-pilot-study\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/lsom.uthscsa.edu\/nephrology\/2019\/07\/16\/high-dose-spironolactone-when-patients-with-acute-decompensated-heart-failure-are-resistant-to-loop-diuretics-a-pilot-study\/","url":"https:\/\/lsom.uthscsa.edu\/nephrology\/2019\/07\/16\/high-dose-spironolactone-when-patients-with-acute-decompensated-heart-failure-are-resistant-to-loop-diuretics-a-pilot-study\/","name":"High-Dose Spironolactone When Patients With Acute Decompensated Heart Failure Are Resistant to Loop Diuretics: A Pilot Study - Nephrology","isPartOf":{"@id":"https:\/\/lsom.uthscsa.edu\/nephrology\/#website"},"primaryImageOfPage":{"@id":"https:\/\/lsom.uthscsa.edu\/nephrology\/2019\/07\/16\/high-dose-spironolactone-when-patients-with-acute-decompensated-heart-failure-are-resistant-to-loop-diuretics-a-pilot-study\/#primaryimage"},"image":{"@id":"https:\/\/lsom.uthscsa.edu\/nephrology\/2019\/07\/16\/high-dose-spironolactone-when-patients-with-acute-decompensated-heart-failure-are-resistant-to-loop-diuretics-a-pilot-study\/#primaryimage"},"thumbnailUrl":"https:\/\/lsom.uthscsa.edu\/nephrology\/wp-content\/uploads\/sites\/38\/2019\/07\/Bansal-v1-v1-resized.jpg","datePublished":"2019-07-16T20:37:59+00:00","dateModified":"2021-03-25T15:11:53+00:00","author":{"@id":"https:\/\/lsom.uthscsa.edu\/nephrology\/#\/schema\/person\/1110032d4e6834fc23a37da5c6fbbc11"},"breadcrumb":{"@id":"https:\/\/lsom.uthscsa.edu\/nephrology\/2019\/07\/16\/high-dose-spironolactone-when-patients-with-acute-decompensated-heart-failure-are-resistant-to-loop-diuretics-a-pilot-study\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/lsom.uthscsa.edu\/nephrology\/2019\/07\/16\/high-dose-spironolactone-when-patients-with-acute-decompensated-heart-failure-are-resistant-to-loop-diuretics-a-pilot-study\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/lsom.uthscsa.edu\/nephrology\/2019\/07\/16\/high-dose-spironolactone-when-patients-with-acute-decompensated-heart-failure-are-resistant-to-loop-diuretics-a-pilot-study\/#primaryimage","url":"https:\/\/lsom.uthscsa.edu\/nephrology\/wp-content\/uploads\/sites\/38\/2019\/07\/Bansal-v1-v1-resized.jpg","contentUrl":"https:\/\/lsom.uthscsa.edu\/nephrology\/wp-content\/uploads\/sites\/38\/2019\/07\/Bansal-v1-v1-resized.jpg","width":666,"height":375,"caption":"Shweta Bansal, MD - Director of Clinical Research, Associate Professor, Program Director-Nephrology Fellowship"},{"@type":"BreadcrumbList","@id":"https:\/\/lsom.uthscsa.edu\/nephrology\/2019\/07\/16\/high-dose-spironolactone-when-patients-with-acute-decompensated-heart-failure-are-resistant-to-loop-diuretics-a-pilot-study\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/lsom.uthscsa.edu\/nephrology\/"},{"@type":"ListItem","position":2,"name":"Uncategorized","item":"https:\/\/lsom.uthscsa.edu\/nephrology\/category\/uncategorized\/"},{"@type":"ListItem","position":3,"name":"News","item":"https:\/\/lsom.uthscsa.edu\/nephrology\/category\/uncategorized\/news\/"},{"@type":"ListItem","position":4,"name":"High-Dose Spironolactone When Patients With Acute Decompensated Heart Failure Are Resistant to Loop Diuretics: A Pilot Study"}]},{"@type":"WebSite","@id":"https:\/\/lsom.uthscsa.edu\/nephrology\/#website","url":"https:\/\/lsom.uthscsa.edu\/nephrology\/","name":"Nephrology","description":"Division of Nephrology","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/lsom.uthscsa.edu\/nephrology\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/lsom.uthscsa.edu\/nephrology\/#\/schema\/person\/1110032d4e6834fc23a37da5c6fbbc11","name":"baumanm","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/4dbea44cb0a308caca16d860c82c3fa9a1c9af9b073c9e8daccad7e4ed1babe7?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/4dbea44cb0a308caca16d860c82c3fa9a1c9af9b073c9e8daccad7e4ed1babe7?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/4dbea44cb0a308caca16d860c82c3fa9a1c9af9b073c9e8daccad7e4ed1babe7?s=96&d=mm&r=g","caption":"baumanm"},"url":"https:\/\/lsom.uthscsa.edu\/nephrology\/author\/baumanm\/"}]}},"_links":{"self":[{"href":"https:\/\/lsom.uthscsa.edu\/nephrology\/wp-json\/wp\/v2\/posts\/1544","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lsom.uthscsa.edu\/nephrology\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lsom.uthscsa.edu\/nephrology\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lsom.uthscsa.edu\/nephrology\/wp-json\/wp\/v2\/users\/111"}],"replies":[{"embeddable":true,"href":"https:\/\/lsom.uthscsa.edu\/nephrology\/wp-json\/wp\/v2\/comments?post=1544"}],"version-history":[{"count":0,"href":"https:\/\/lsom.uthscsa.edu\/nephrology\/wp-json\/wp\/v2\/posts\/1544\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/lsom.uthscsa.edu\/nephrology\/wp-json\/wp\/v2\/media\/1550"}],"wp:attachment":[{"href":"https:\/\/lsom.uthscsa.edu\/nephrology\/wp-json\/wp\/v2\/media?parent=1544"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lsom.uthscsa.edu\/nephrology\/wp-json\/wp\/v2\/categories?post=1544"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lsom.uthscsa.edu\/nephrology\/wp-json\/wp\/v2\/tags?post=1544"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}